Recent 8-K filings for SYK

• May 20, 2026 20:21 UTC leadership materiality 0.35 neutral item 5.02item 9.01

  Stryker CAO Berry to retire Sept 1, 2026; Baculik named successor as VP, CAO

  William Berry retires as VP, CAO effective Sept 1, 2026; will serve as Advisor to CFO until Aug 15, 2027.

• May 08, 2026 23:59 UTC other_material materiality 0.25 neutral item 5.07

  Stryker shareholders elect directors, ratify auditor, approve exec compensation

  All ten director nominees elected; Emmanuel P. Maceda had highest dissent with 52.4M against (out of ~290M votes cast).

• Apr 30, 2026 23:59 UTC earnings materiality 0.65 neutral item 2.02item 9.01

  Stryker Q1 net sales $6.0B up 2.6%; adjusted EPS down 8.5% to $2.60; maintains FY guidance

  Net sales $6.0B (+2.6% reported, +2.4% organic); MedSurg/Neuro +5.0%, Orthopaedics +0.1%.

• Apr 09, 2026 23:59 UTC cyber materiality 0.85 negative item 1.05item 7.01

  Stryker says cyber incident materially impacted Q1 operations and financial results; full-year guidance unchanged

  Incident identified March 11, 2026; caused business disruptions.

• Mar 23, 2026 23:59 UTC cyber materiality 0.70 negative item 7.01item 9.01

  Stryker updates cyber incident: contained, no customer data accessed per Unit 42

  Threat actor used malicious file to hide activity; file not capable of spreading internally or externally.

• Mar 12, 2026 23:59 UTC cyber materiality 0.75 negative item 7.01

  Stryker updates on cyber incident: operations disrupted, patient services unaffected

  Cybersecurity incident affecting Microsoft environment disclosed March 11; CISO provided update March 12.

• Mar 11, 2026 23:59 UTC cyber materiality 0.65 negative item 8.01

  Stryker reports global cybersecurity incident affecting Microsoft systems; investigation ongoing

  Incident detected March 11, 2026; global disruption to Microsoft environment; no ransomware or malware; contained.

• Jan 29, 2026 23:59 UTC earnings materiality 0.75 positive item 2.02item 9.01

  Stryker reports Q4 2025 sales $7.2B, +11% organic; 2026 outlook 8-9.5% organic growth

  Q4 reported EPS $2.20 (+56% YoY); adjusted EPS $4.47 (+11.5%).

• Dec 04, 2025 23:59 UTC leadership materiality 0.55 neutral item 5.02item 7.01item 9.01

  Stryker appoints Spencer Stiles as President and COO; Crotty promoted to Group President Orthopaedics

  Spencer Stiles appointed President & COO effective Jan 1, 2026; will lead global businesses, strategy, and M&A.

• Oct 30, 2025 23:59 UTC earnings materiality 0.80 positive item 2.02item 9.01

  Stryker Q3 net sales +10.3% to $6.1B; raises FY 2025 guidance

  Reported EPS $2.22 (+2.8%); adjusted EPS $3.19 (+11.1%).

• Jul 31, 2025 23:59 UTC earnings materiality 0.75 positive item 2.02item 9.01

  Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance

  Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.70 · Most common event earnings

3 positive 4 negative 4 neutral

source · SYK on sec.gov